DBP and breast carcinoma: When we performed cell death measurements at 96 h, we could observe that sequential treatment with A-133 after S63845 caused a strong synergy in these cells (CI = 0.43) (Fig. 3B) as predicted by DBP (Fig. 3A), and as previously observed in breast cancer [51].